$BRZE

Braze, Inc.

CIK:0001676238|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Revenue	$ 227,230	$ 180,111	$ 438,229	$ 342,170
Cost of revenue	75,374	58,221	147,710	109,078
Gross Profit	151,856	121,890	290,519	233,092
Operating expenses:
Sales and marketing	92,878	82,599	182,066	156,726
Research and development	45,275	41,250	91,375	78,047
General and administrative	31,826	36,794	62,715	77,294
Total operating expenses	169,979	160,643	336,156	312,067
Loss from operations	(18,123)	(38,753)	(45,637)	(78,975)
Other income, net	2,299	3,983	5,749	9,635
Loss before provision for income taxes	(15,824)	(34,770)	(39,888)	(69,340)
Provision for (benefit from) income taxes	2,484	(7,007)	3,912	(5,936)
Net loss	(18,308)	(27,763)	(43,800)	(63,404)
Net income attributable to redeemable non-controlling interest	545	136	1,644	281
Net loss attributable to Braze, Inc.	$ (18,853)	$ (27,899)	$ (45,444)	$ (63,685)
Earnings Per Share
Net loss per share attributable to Braze, Inc. common stockholders, basic (in dollars per share)	$ (0.17)	$ (0.26)	$ (0.41)	$ (0.60)
Net loss per share attributable to Braze, Inc. common stockholders, diluted (in dollars per share)	$ (0.17)	$ (0.26)	$ (0.41)	$ (0.60)
Weighted-Average Shares Outstanding
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, basic (in shares)	111,252	106,807	111,028	105,858
Weighted-average shares used to compute net loss per share attributable to Braze, Inc. common stockholders, diluted (in shares)	111,252	106,807	111,028	105,858

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss (including amounts attributable to redeemable non-controlling interest)	$ (43,800)	$ (63,404)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation	71,508	68,198
Amortization of deferred contract costs	25,138	19,451
Depreciation and amortization	12,566	7,372
Provision for credit losses	(140)	600
Value of common stock donated to charity	1,083	1,860
Accretion of discount on marketable securities	(144)	(654)
Non-cash foreign exchange loss	151	209
Deferred tax asset	(263)	0
Other	17	28
Changes in operating assets and liabilities:
Accounts receivable	9,891	11,549
Prepaid expenses and other current assets	(14,042)	5,036
Deferred contract costs	(31,266)	(24,814)
ROU assets and liabilities	(693)	(314)
Other assets	(1,957)	(8,451)
Accounts payable	(133)	(1,159)
Accrued expenses and other current liabilities	(15,270)	1,218
Deferred revenue	42,465	14,493
Other long-term liabilities	(2,773)	(122)
Net cash provided by operating activities	52,338	31,096
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for acquisition, net of cash acquired	0	(181,200)
Purchases of property and equipment	(1,278)	(2,826)
Capitalized internal-use software costs	(2,525)	(1,865)
Purchases of marketable securities	(57,965)	(75,115)
Maturities of marketable securities	58,865	102,540
Return of principal on marketable securities	41,674	120,753
CASH FLOWS FROM FINANCING ACTIVITIES:	38,771	(37,713)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of common stock options	982	3,201
Proceeds from stock associated with employee stock purchase plan	4,745	4,882
Repayments of finance lease - principal	(245)	0
Tax withholding related to net share settlements of stock-based compensation awards	(3,616)	0
Repurchase of common stock	(50,000)	0
Net cash provided by / (used in) financing activities	(48,134)	8,083
Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash	(547)	642
Net change in cash, cash equivalents, and restricted cash	42,428	2,108
Net change in cash, cash equivalents, and restricted cash	128,338	83,592
Cash, cash equivalents, and restricted cash, end of period	170,766	85,700
SUPPLEMENTAL CASH FLOW DISCLOSURE:
Cash paid for income taxes, net of refunds	3,357	3,309
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized to internal-use software	1,302	1,051
Unrealized net loss on marketable investment securities	(2,051)	(307)
Net change to property and equipment (included in accounts payable/accrued liabilities)	112	496
Asset retirement obligation	19	19
Common stock issuance, acquisition	0	(108,695)
Indemnity escrows, acquisition	0	3,782
Excise tax on stock repurchase (included in accrued liabilities)	272	0
Measurement period adjustment relating to business acquisitions	$ (263)	$ 0

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2026	Jan. 31, 2026
CURRENT ASSETS:
Cash and cash equivalents	$ 166,770	$ 124,342
Restricted cash, current	566	566
Accounts receivable, net of allowance of $1,469 and $1,934, respectively	112,474	122,350
Marketable securities	243,099	287,580
Prepaid expenses and other current assets	47,089	33,088
Total current assets	569,998	567,926
Restricted cash, noncurrent	3,430	3,430
Property and equipment, net	41,933	43,517
Finance lease right-of-use assets	15,213	0
Operating lease right-of-use assets	71,561	72,011
Deferred contract costs	106,812	100,738
Goodwill	262,120	261,857
Intangible assets, net	55,556	61,487
Other assets	4,742	2,791
TOTAL ASSETS	1,131,365	1,113,757
CURRENT LIABILITIES:
Accounts payable	1,535	1,562
Accrued expenses and other current liabilities	79,231	95,023
Deferred revenue	346,716	304,560
Finance lease liabilities, current	4,209	0
Operating lease liabilities, current	18,722	19,269
Total current liabilities	450,413	420,414
Finance lease liabilities, noncurrent	11,053	0
Operating lease liabilities, noncurrent	62,423	63,385
Other long-term liabilities	5,247	5,802
TOTAL LIABILITIES	529,136	489,601
COMMITMENTS AND CONTINGENCIES (Note 13)
Redeemable non-controlling interest (Note 4)	2,033	389
STOCKHOLDERS’ EQUITY
Additional paid-in capital	1,364,196	1,340,091
Accumulated other comprehensive income (loss)	(444)	1,788
Accumulated deficit	(763,567)	(718,123)
TOTAL STOCKHOLDERS’ EQUITY	600,196	623,767
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERS’ EQUITY	1,131,365	1,113,757
Class A common stock
STOCKHOLDERS’ EQUITY
Common stock	$ 11	$ 11